Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, MDS, Adult, Combination therapy, MPN, Clinical Research, Chronic Myeloid Malignancies, CMML, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous)
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, MDS, Adult, Combination therapy, MPN, Clinical Research, Chronic Myeloid Malignancies, CMML, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous)
Monday, December 9, 2024: 4:30 PM-6:00 PM
Room 6A
(San Diego Convention Center)
Moderators:
Gabriela Sanchez-Petitto, MD, The Ohio State University
and
Simona Pagliuca, MD, PhD, Nancy University Hospital
Disclosures:
Sanchez-Petitto: GamidaCell: Consultancy; Bristol-Myers Squibb: Research Funding. Pagliuca: Alexion: Consultancy, Honoraria; Sobi: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Jazz: Consultancy, Honoraria.
This session consists of abstracts describing clinical trials of maintenance therapy after allogeneic hematopoietic cell transplant as well as treatment of relapsed disease after treatment.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH